Anesthesia management in hepatic echinococcosis surgery_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

GONG Zhiying ,  ZHANG Weiyi

Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding?author：

ZHANG Weiyi, Email: zhangweiyi@wchscu.cn

Keywords：

hepatic echinococcosis; hepatic hydatid disease; surgery; anesthesia management

DOI：

10.7507/1007-9424.202407084

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

We reviewed the research progress of anesthesia management in hepatic echinococcosis surgery in recent years, including the key technologies, practical experience, and research progress of anesthesia management in hepatic echinococcosis surgery, so as to guide clinical practice. Firstly, in the selection of anesthesia, the general anesthesia combined with epidural block or regional nerve block is recommended to improve surgical safety and patients’ comfort. At the same time, the importance of intraoperative continuous monitoring, including key indicators such as hemodynamics and respiratory function, is emphasized, and transesophageal echocardiography and brain function monitoring techniques are introduced to optimize anesthesia management. Finally, the concept of enhanced recovery after surgery is promoted, and measures such as preoperative optimization, intraoperative heat preservation, refined fluid management, and postoperative analgesic management are implemented to promote the rapid recovery of patients. At the same time, some challenges and unsolved problems in the current research also are pointed out, such as complex case evaluation, complications prevention, and teamwork, etc., which need to be further studied in the future to optimize the anesthesia strategy.

Citation： GONG Zhiying, ZHANG Weiyi. Anesthesia management in hepatic echinococcosis surgery. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2024, 31(10): 1181-1187. doi: 10.7507/1007-9424.202407084 Copy

1.	A JD, Chai JP, Jia SL, et al. Historical changes in surgical strategy and complication management for hepatic cystic echinococcosis. World J Gastrointest Surg, 2023, 15(8): 1591-1599.
2.	Brunetti E, Kern P, Vuitton DA, et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop, 2010, 114(1): 1-16.
3.	Berto CG, Liou P, Coyle CM, et al. Surgical management of cystic echinococcosis of the liver. Curr Opin Infect Dis, 2023, 36(5): 348-352.
4.	Wan L, Wang T, Cheng L, et al. Laparoscopic treatment strategies for liver echinococcosis. Infect Dis Ther, 2022, 11(4): 1415-1426.
5.	Bresson-Hadni S, Koch S, Beurton I, et al. Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients. Hepatology, 1999, 30(4): 857-864.
6.	Zhang T, Li B, Liu Y, et al. Risk factors associated with echinococcosis in the general Chinese population: a meta-analysis and systematic review. Front Public Health, 2022, 10: 821265. doi: 10.3389/fpubh.2022.821265.
7.	茍棋玲. 高原肺動脈高壓危險因素及對心臟結構功能影響研究. 成都: 四川大學, 2021.
8.	Liu JJ, Sun YM, Xu Y, et al. Pathophysiological consequences and treatment strategy of obstructive jaundice. World J Gastrointest Surg, 2023, 15(7): 1262-1276.
9.	陳欣, 陳琳. 肝硬化心肌病發病機制與臨床相關性研究現況. 肝臟, 2023, 28(1): 121-124.
10.	Liu H, Jayakumar S, Traboulsi M, et al. Cirrhotic cardiomyopathy: Implications for liver transplantation. Liver Transpl, 2017, 23(6): 826-835.
11.	郭瀟瀟, 張抒揚. 心臟包蟲病的診治. 中華內科雜志, 2011, 50(12): 1061-1062.
12.	Gómez R, Moreno E, Loinaz C, et al. Diaphragmatic or transdiaphragmatic thoracic involvement in hepatic hydatid disease: surgical trends and classification. World J Surg, 1995, 19(5): 714-719.
13.	Agudelo Higuita NI, Brunetti E, McCloskey C. Cystic echinococcosis. J Clin Microbiol, 2016, 54(3): 518-523.
14.	León-Velarde F, Maggiorini M, Reeves JT, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol, 2005, 6(2): 147-157.
15.	祁生貴, 吳天一. 慢性高原病診斷標準及相關研究. 高原醫學雜志, 2015, 25(4): 1-11.
16.	Villán González A, Pérez Pariente JM, Barreiro Alonso E. Obstructive jaundice secondary to a hepatic hydatid cyst. Rev Esp Enferm Dig, 2018, 110(11): 741-742.
17.	Dolay K, Akbulut S. Role of endoscopic retrograde cholangiopancreatography in the management of hepatic hydatid disease. World J Gastroenterol, 2014, 20(41): 15253-15261.
18.	Yücesoy AN, Po?an S. Secondary gallbladder hydatidosis and nonfragmanted germinative membrane sourced obstructive jaundice caused by intrabiliary ruptured hepatic hydatid cyst (a case report): two rare complication of the intrabiliary ruptured hepatic hydatid cyst. Hepatobiliary Surg Nutr, 2014, 3(4): 209-211.
19.	Akbulut S, Yavuz R, Sogutcu N, et al. Hydatid cyst of the pancreas: Report of an undiagnosed case of pancreatic hydatid cyst and brief literature review. World J Gastrointest Surg, 2014, 6(10): 190-200.
20.	Mihetiu A, Bratu DG, Sabau D, et al. Primary hydatid cyst of the pancreas: A literature review on a rare and challenging occurrence of echinococcosis. Cureus, 2024, 16(5): e60797. doi: 10.7759/cureus.60797.
21.	Aziz F, Pandya T, Patel HV, et al. Nephrotic presentation in hydatid cyst disease with predominant tubulointerstital disease. Int J Nephrol Renovasc Dis, 2009, 2: 23-26.
22.	Gelman R, Brook G, Green J, et al. Minimal change glomerulonephritis associated with hydatid disease. Clin Nephrol, 2000, 53: 152-155.
23.	Ali-Khan Z, Rausch RL. Demonstration of amyloid and immune complex deposits in renal and hepatic parenchyma of Alaskan alveolar hydatid disease patients. Ann Trop Med Parasitol, 1987, 81(4): 381-392.
24.	葉芳, 黃文起. 加速康復外科發展與完善麻醉管理. 廣東醫學, 2016, 37(18): 2692-2695.
25.	龔財芳, 熊永福, 趙俊宇, 等. 肝移植受者營養評估與營養支持進展. 器官移植, 2023, 14(6): 905-912.
26.	Wang Z, Xu J, Song G, et al. Nutritional status and screening tools to detect nutritional risk in hospitalized patients with hepatic echinococcosis. Parasite, 2020, 27: 74. doi: 10.1051/parasite/2020071.
27.	Lim DS. Prehabilitation—Is it worth our while?. Am J Phys Med Rehabil, 2015, 94(8): e74. doi: 10.1097/PHM.0000000000000316.
28.	馮碧, 許瑞華. 三聯預康復策略在肝癌腹腔鏡肝切除術中的應用價值. 現代腫瘤醫學, 2019, 27(10): 1761-1765.
29.	孫慧慧, 孫菊, 程莉潔, 等. 肝移植受者術前預康復的研究進展. 護理學報, 2022, 29(15): 39-44.
30.	Bayramov N, Mammadova S. A review of the current ERAS guidelines for liver resection, liver transplantation and pancreatoduodenectomy. Ann Med Surg (Lond), 2022, 82: 104596. doi: 10.1016/j.amsu.2022.104596.
31.	Melloul E, Hübner M, Scott M, et al. Guidelines for perioperative care for liver surgery: Enhanced Recovery After Surgery (ERAS) society recommendations. World J Surg, 2016, 40(10): 2425-2440.
32.	Melis GC, van Leeuwen PA, von Blomberg-van der Flier BM, et al. A carbohydrate-rich beverage prior to surgery prevents surgery-induced immunodepression: a randomized, controlled, clinical trial. JPEN J Parenter Enteral Nutr, 2006, 30(1): 21-26.
33.	Beyer TA, Werner S. The cytoprotective Nrf2 transcription factor controls insulin receptor signaling in the regenerating liver. Cell Cycle, 2008, 7(7): 874-878.
34.	Song JG, Cao YF, Yang LQ, et al. Awakening concentration of desflurane is decreased in patients with obstructive jaundice. Anesthesiology, 2005, 102(3): 562-565.
35.	Yang LQ, Song JC, Irwin MG, et al. A clinical prospective comparison of anesthetics sensitivity and hemodynamic effect among patients with or without obstructive jaundice. Acta Anaesthesiol Scand, 2010, 54(7): 871-877.
36.	Wang ZM, Zhang P, Lin MJ, et al. Influence of obstructive jaundice on pharmacodynamics of rocuronium. PLoS One, 2013, 8(10): e78052. doi: 10.1371/journal.pone.0078052.
37.	Wang Z, Bao Y, Lu Z, et al. Is neuromuscular relaxation of rocuronium prolonged in patients with obstructive jaundice?. Med Hypotheses, 2011, 76(1): 100-101.
38.	Song JC, Sun YM, Zhang MZ, et al. The etomidate requirement is decreased in patients with obstructive jaundice. Anesth Analg, 2011, 113(5): 1028-1032.
39.	Yamamoto K, Fukumori D, Yamamoto F, et al. First report of hepatectomy without endotracheal general anesthesia. J Am Coll Surg, 2013, 216(5): 908-914.
40.	Groeben H. Epidural anesthesia and pulmonary function. J Anesth, 2006, 20(4): 290-299.
41.	Tzimas P, Prout J, Papadopoulos G, et al. Epidural anaesthesia and analgesia for liver resection. Anaesthesia, 2013, 68(6): 628-635.
42.	Carli F, Clemente A. Regional anesthesia and enhanced recovery after surgery. Minerva Anestesiol, 2014, 80(11): 1228-1233.
43.	古麗娜·塔林巴依, 安玉潔, 劉玉革, 等. 兩種不同麻醉方式在肝包蟲病患者中的應用價值分析. 中西醫結合心血管病電子雜志, 2020, 8(26): 2-4.
44.	陳慶彬, 唐璟. 不同麻醉方式對肝包蟲手術中應激反應的影響. 青海醫藥雜志, 2023, 53(9): 11-14.
45.	Ball J. How useful is the bispectral index in the management of ICU patients?. Minerva Anestesiol, 2002, 68(4): 248-251.
46.	Savage RM, Aronson S原著. 李立環主譯. 術中經食管超聲心動圖. 北京: 人民衛生出版社, 2011: 214-247.
47.	經食管超聲心動圖臨床應用中國專家共識專家組. 經食管超聲心動圖臨床應用中國專家共識. 中國循環雜志, 2018, 33(1): 11-23.
48.	姜徽, 汪歡, 黃丹, 等. 肺保護性通氣策略對高原地區肝包蟲根治術患者術后氧合功能的影響. 麻醉安全與質控, 2020, 4(6): 341-344.
49.	易慧敏, 蔡常潔, 陸敏強, 等. 肝移植術后急性肺損傷的治療策略. 中華外科雜志, 2006, 44(13): 889-893.
50.	Yamamoto K, Ishizawa T, Kokudo N. Laparoscopic hepatectomy under epidural anesthesia. Ann Surg, 2014, 260(2): e1. doi: 10.1097/SLA.0000000000000816.
51.	史佳, 余劍波, 宮麗榮, 等. 電針減輕內毒素休克誘發兔急性肺損傷的機制: 與Nrf2/ARE通路的關系. 中華麻醉學雜志, 2014, 34(7): 843-847.
52.	任秋生, 王均爐, 陳雪琴, 等. 經皮穴位電刺激合谷足三里對單肺通氣所致炎性反應的抑制作用. 中華中醫藥學刊, 2011, 29(10): 2326-2328.
53.	McLain N, Parks S, Collins MJ. Perioperative goal-directed fluid therapy: a prime component of enhanced recovery after surgery. AANA J, 2021, 89(4): 351-357.
54.	Virág M, Rottler M, Gede N, et al. Goal-directed fluid therapy enhances gastrointestinal recovery after laparoscopic surgery: a systematic review and meta-analysis. J Pers Med, 2022, 12(5): 734. doi: 10.3390/jpm12050734.
55.	梁超琴, 張光英, 林成新, 等. 以脈壓變異率為目標導向的液體治療在開腹肝臟手術中的應用效果. 廣西醫學, 2021, 43(2): 155-159.
56.	Wrzosek A, Jakowicka-Wordliczek J, Zajaczkowska R, et al. Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery. Cochrane Database Syst Rev, 2019, 12(12): CD012767. doi: 10.1002/14651858.CD012767.pub2.
57.	Chu MW, Losenno KL, Moore K, et al. Blood conservation strategies reduce the need for transfusions in ascending and aortic arch surgery. Perfusion, 2013, 28(4): 315-321.
58.	樊理華, 王建平, 鄭旺福, 等. 術前預防性應用烏司他丁對肝切除術中血液保護作用的影響. 臨床外科雜志, 2005, 13(5): 309-310.
59.	朱榮濤, 郭文治, 李捷, 等. 控制性低中心靜脈壓在腹腔鏡肝葉切除術中的應用. 中國普通外科雜志, 2018, 27(1): 42-48.
60.	王庚, 吳新民. 急性等容性血液稀釋與凝血狀態. 中華麻醉學雜志, 2001, 21(11): 645-648.
61.	盛博, 張幫健, 楊昶. 控制性低中心靜脈壓聯合急性高容性血液稀釋在右半肝切除術中的應用. 四川醫學, 2017, 38(12): 1403-1406.
62.	夏宗敬, 謝琳麗, 廖刃, 等. POTTS指導高原地區高血紅蛋白患者輸血安全有效性的研究. 西藏醫藥, 2019, 40(1): 7-8.
63.	Knaepel A. Inadvertent perioperative hypothermia: a literature review. J Perioper Pract, 2012, 22(3): 86-90.
64.	Zhou YD, Zhang WY, Xie GH, et al. Inadvertent perioperative hypothermia and surgical site infections after liver resection. Hepatobiliary Pancreat Dis Int, 2023, S1499-3872(23): 00244-8. doi: 10.1016/j.hbpd.2023.12.006.
65.	Dieu A, Huynen P, Lavand’homme P, et al. Pain management after open liver resection: Procedure-Specific Postoperative Pain Management (PROSPECT) recommendations. Reg Anesth Pain Med, 2021, 46(5): 433-445.
66.	Sessler DI, Pei L, Li K, et al. Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial. Lancet, 2022, 399(10337): 1799-1808.
67.	次仁德吉, 王盈兵. 成人肝包蟲手術的麻醉管理. 西藏醫藥, 2019, 40(3): 42-43.
68.	蔡誠毅, 馬武華. 全麻誘導后支氣管痙攣一例. 臨床麻醉學雜志, 2012, 28(5): 453.
69.	劉冬杰. 肝包蟲內囊摘除術中支氣管痙攣、過敏性休克1例的麻醉處理. 臨床合理用藥雜志, 2009, 2(8): 48.
70.	Paksoy Y, Odev K, Sahin M, et al. Percutaneous treatment of liver hydatid cysts: comparison of direct injection of albendazole and hypertonic saline solution. AJR Am J Roentgenol, 2005, 185(3): 727-734.
71.	Albi A, Baudin F, Matmar M, et al. Severe hypernatremia after hypertonic saline irrigation of hydatid cysts. Anesth Analg, 2002, 95(6): 1806-1808.
72.	Yun G, Baek SH, Kim S. Evaluation and management of hypernatremia in adults: clinical perspectives. Korean J Intern Med, 2023, 38(3): 290-302.
73.	Kuzmanovska B, Kartalov A, Kuzmanovski I, et al. Hypernatremia-induced neurologic complications after hepatic hydatid cyst surgery: pretreat to prevent. Med Arch, 2019, 73(5): 356-358.
74.	肖迪, 時瑩慶, 關巍, 等. 高原環境在血栓形成及血栓栓塞性疾病發病中作用的研究進展. 山東醫藥, 2017, 57(47): 102-106.
75.	Melloul E, Dondéro F, Vilgrain V, et al. Pulmonary embolism after elective liver resection: a prospective analysis of risk factors. J Hepatol, 2012, 57(6): 1268-1275.
76.	Ejaz A, Spolverato G, Kim Y, et al. Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg, 2014, 18(6): 1116-1124.
77.	Turley RS, Reddy SK, Shortell CK, et al. Venous thromboembolism after hepatic resection: analysis of 5 706 patients. J Gastrointest Surg, 2012, 16(9): 1705-1714.
78.	Bell BR, Bastien PE, Douketis JD, et al. Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review. Can J Anaesth, 2015, 62(2): 194-202.
79.	Lui B, Wee B, Lai J, et al. A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant—Has venous thromboembolism treatment become safer?. Thromb Res, 2022, 219: 112-120.
80.	Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv, 2020, 4(19): 4693-4738.
81.	Stevens SM, Woller SC, Baumann Kreuziger L, et al. Executive summary: antithrombotic therapy for VTE disease: Second update of the CHEST guideline and expert panel report. Chest, 2021, 160(6): 2247-2259.
82.	Crile GW. The kinetic theory of shock and its prevention through anoci-association. Lancet, 1913, 185: 7-16.
83.	Xuan C, Yan W, Wang D, et al. Efficacy of preemptive analgesia treatments for the management of postoperative pain: a network meta-analysis. Br J Anaesth, 2022, 129(6): 946-958.
84.	翁方澤, 吳維, 朱嶺, 等. 納布啡超前鎮痛模式在腹腔鏡肝部分切除手術中的臨床應用效果探究. 江漢大學學報(自然科學版), 2022, 50(5): 69-74.
85.	楊秋紅, 戴曉薇, 張益維, 等. 帕瑞昔布超前鎮痛對開腹肝切除術后疼痛及應激、炎癥反應的影響. 中國衛生檢驗雜志, 2019, 29(21): 2632-2634.
86.	Doleman B, Leonardi-Bee J, Heinink TP, et al. Pre-emptive and preventive NSAIDs for postoperative pain in adults undergoing all types of surgery. Cochrane Database Syst Rev, 2021, 6(6): CD012978. doi: 10.1002/14651858.CD012978.pub2.
87.	Bai JW, An D, Perlas A, et al. Adjuncts to local anesthetic wound infiltration for postoperative analgesia: a systematic review. Reg Anesth Pain Med, 2020, 45(8): 645-655.
88.	Ballantyne JC, Carr DB, deFerranti S, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg, 1998, 86(3): 598-612.
89.	高琳, 劉玉革. 肝包蟲囊外切除病人術后不同鎮痛方法的比較. 西部醫學, 2009, 21(1): 73-75.
90.	文成措. 不同麻醉鎮痛方式對肝包蟲手術患者術后轉歸的影響. 臨床醫藥文獻電子雜志, 2020, 7(7): 19.
91.	Su W, Deng X, Li X, et al. Effect of the transversus abdominis plane block on postoperative pain and recovery in patients with hepatic echinococcosis. J Int Med Res, 2018, 46(9): 3563-3569.
92.	Daghmouri MA, Mesbahi M, Akremi S, et al. Efficacy of bilateral erector spinae block for post-operative analgesia in liver hydatid surgery. Br J Pain, 2021, 15(4): 376-379.
93.	Verhoef C, Singla N, Moneta G, etal. Fibrocaps for surgical hemostasis: two randomized, controlled phase Ⅱ trials. J Surg Res, 2015, 194(2): 679-687.
94.	Joliat GR, Kobayashi K, Hasegawa K, et al. Guidelines for perioperative care for liver surgery: Enhanced Recovery After Surgery (ERAS) society recommendations 2022. World J Surg, 2023, 47(1): 11-34.
95.	Darvall JN, Handscombe M, Leslie K. Chewing gum for the treatment of postoperative nausea and vomiting: a pilot randomized controlled trial. Br J Anaesth, 2017, 118(1): 83-89.
96.	Chen X, Chang C, Yuan X, et al. Efficacy and safety of preoperative chewing gum for undergoing elective surgery: A meta-analysis of randomised controlled trials. J Clin Nurs, 2023, 32(15-16): 4295-4310.
97.	陳鳳, 楊雪, 劉麗, 等. 內關穴按壓改善癌癥病人化療相關性惡心、嘔吐效果的Meta分析. 護理研究, 2020, 34(9): 1535-1541.
98.	周璇, 王琦. 穴位按壓腕帶緩解術后惡心嘔吐隨機對照試驗的Meta分析. 護理學雜志, 2011, 26(6): 81-84.
99.	Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: Advances in the 21st century. Clin Microbiol Rev, 2019, 32(2): e00075-18. doi: 10.1128/CMR.00075-18.

1. A JD, Chai JP, Jia SL, et al. Historical changes in surgical strategy and complication management for hepatic cystic echinococcosis. World J Gastrointest Surg, 2023, 15(8): 1591-1599.
2. Brunetti E, Kern P, Vuitton DA, et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop, 2010, 114(1): 1-16.
3. Berto CG, Liou P, Coyle CM, et al. Surgical management of cystic echinococcosis of the liver. Curr Opin Infect Dis, 2023, 36(5): 348-352.
4. Wan L, Wang T, Cheng L, et al. Laparoscopic treatment strategies for liver echinococcosis. Infect Dis Ther, 2022, 11(4): 1415-1426.
5. Bresson-Hadni S, Koch S, Beurton I, et al. Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients. Hepatology, 1999, 30(4): 857-864.
6. Zhang T, Li B, Liu Y, et al. Risk factors associated with echinococcosis in the general Chinese population: a meta-analysis and systematic review. Front Public Health, 2022, 10: 821265. doi: 10.3389/fpubh.2022.821265.
7. 茍棋玲. 高原肺動脈高壓危險因素及對心臟結構功能影響研究. 成都: 四川大學, 2021.
8. Liu JJ, Sun YM, Xu Y, et al. Pathophysiological consequences and treatment strategy of obstructive jaundice. World J Gastrointest Surg, 2023, 15(7): 1262-1276.
9. 陳欣, 陳琳. 肝硬化心肌病發病機制與臨床相關性研究現況. 肝臟, 2023, 28(1): 121-124.
10. Liu H, Jayakumar S, Traboulsi M, et al. Cirrhotic cardiomyopathy: Implications for liver transplantation. Liver Transpl, 2017, 23(6): 826-835.
11. 郭瀟瀟, 張抒揚. 心臟包蟲病的診治. 中華內科雜志, 2011, 50(12): 1061-1062.
12. Gómez R, Moreno E, Loinaz C, et al. Diaphragmatic or transdiaphragmatic thoracic involvement in hepatic hydatid disease: surgical trends and classification. World J Surg, 1995, 19(5): 714-719.
13. Agudelo Higuita NI, Brunetti E, McCloskey C. Cystic echinococcosis. J Clin Microbiol, 2016, 54(3): 518-523.
14. León-Velarde F, Maggiorini M, Reeves JT, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol, 2005, 6(2): 147-157.
15. 祁生貴, 吳天一. 慢性高原病診斷標準及相關研究. 高原醫學雜志, 2015, 25(4): 1-11.
16. Villán González A, Pérez Pariente JM, Barreiro Alonso E. Obstructive jaundice secondary to a hepatic hydatid cyst. Rev Esp Enferm Dig, 2018, 110(11): 741-742.
17. Dolay K, Akbulut S. Role of endoscopic retrograde cholangiopancreatography in the management of hepatic hydatid disease. World J Gastroenterol, 2014, 20(41): 15253-15261.
18. Yücesoy AN, Po?an S. Secondary gallbladder hydatidosis and nonfragmanted germinative membrane sourced obstructive jaundice caused by intrabiliary ruptured hepatic hydatid cyst (a case report): two rare complication of the intrabiliary ruptured hepatic hydatid cyst. Hepatobiliary Surg Nutr, 2014, 3(4): 209-211.
19. Akbulut S, Yavuz R, Sogutcu N, et al. Hydatid cyst of the pancreas: Report of an undiagnosed case of pancreatic hydatid cyst and brief literature review. World J Gastrointest Surg, 2014, 6(10): 190-200.
20. Mihetiu A, Bratu DG, Sabau D, et al. Primary hydatid cyst of the pancreas: A literature review on a rare and challenging occurrence of echinococcosis. Cureus, 2024, 16(5): e60797. doi: 10.7759/cureus.60797.
21. Aziz F, Pandya T, Patel HV, et al. Nephrotic presentation in hydatid cyst disease with predominant tubulointerstital disease. Int J Nephrol Renovasc Dis, 2009, 2: 23-26.
22. Gelman R, Brook G, Green J, et al. Minimal change glomerulonephritis associated with hydatid disease. Clin Nephrol, 2000, 53: 152-155.
23. Ali-Khan Z, Rausch RL. Demonstration of amyloid and immune complex deposits in renal and hepatic parenchyma of Alaskan alveolar hydatid disease patients. Ann Trop Med Parasitol, 1987, 81(4): 381-392.
24. 葉芳, 黃文起. 加速康復外科發展與完善麻醉管理. 廣東醫學, 2016, 37(18): 2692-2695.
25. 龔財芳, 熊永福, 趙俊宇, 等. 肝移植受者營養評估與營養支持進展. 器官移植, 2023, 14(6): 905-912.
26. Wang Z, Xu J, Song G, et al. Nutritional status and screening tools to detect nutritional risk in hospitalized patients with hepatic echinococcosis. Parasite, 2020, 27: 74. doi: 10.1051/parasite/2020071.
27. Lim DS. Prehabilitation—Is it worth our while?. Am J Phys Med Rehabil, 2015, 94(8): e74. doi: 10.1097/PHM.0000000000000316.
28. 馮碧, 許瑞華. 三聯預康復策略在肝癌腹腔鏡肝切除術中的應用價值. 現代腫瘤醫學, 2019, 27(10): 1761-1765.
29. 孫慧慧, 孫菊, 程莉潔, 等. 肝移植受者術前預康復的研究進展. 護理學報, 2022, 29(15): 39-44.
30. Bayramov N, Mammadova S. A review of the current ERAS guidelines for liver resection, liver transplantation and pancreatoduodenectomy. Ann Med Surg (Lond), 2022, 82: 104596. doi: 10.1016/j.amsu.2022.104596.
31. Melloul E, Hübner M, Scott M, et al. Guidelines for perioperative care for liver surgery: Enhanced Recovery After Surgery (ERAS) society recommendations. World J Surg, 2016, 40(10): 2425-2440.
32. Melis GC, van Leeuwen PA, von Blomberg-van der Flier BM, et al. A carbohydrate-rich beverage prior to surgery prevents surgery-induced immunodepression: a randomized, controlled, clinical trial. JPEN J Parenter Enteral Nutr, 2006, 30(1): 21-26.
33. Beyer TA, Werner S. The cytoprotective Nrf2 transcription factor controls insulin receptor signaling in the regenerating liver. Cell Cycle, 2008, 7(7): 874-878.
34. Song JG, Cao YF, Yang LQ, et al. Awakening concentration of desflurane is decreased in patients with obstructive jaundice. Anesthesiology, 2005, 102(3): 562-565.
35. Yang LQ, Song JC, Irwin MG, et al. A clinical prospective comparison of anesthetics sensitivity and hemodynamic effect among patients with or without obstructive jaundice. Acta Anaesthesiol Scand, 2010, 54(7): 871-877.
36. Wang ZM, Zhang P, Lin MJ, et al. Influence of obstructive jaundice on pharmacodynamics of rocuronium. PLoS One, 2013, 8(10): e78052. doi: 10.1371/journal.pone.0078052.
37. Wang Z, Bao Y, Lu Z, et al. Is neuromuscular relaxation of rocuronium prolonged in patients with obstructive jaundice?. Med Hypotheses, 2011, 76(1): 100-101.
38. Song JC, Sun YM, Zhang MZ, et al. The etomidate requirement is decreased in patients with obstructive jaundice. Anesth Analg, 2011, 113(5): 1028-1032.
39. Yamamoto K, Fukumori D, Yamamoto F, et al. First report of hepatectomy without endotracheal general anesthesia. J Am Coll Surg, 2013, 216(5): 908-914.
40. Groeben H. Epidural anesthesia and pulmonary function. J Anesth, 2006, 20(4): 290-299.
41. Tzimas P, Prout J, Papadopoulos G, et al. Epidural anaesthesia and analgesia for liver resection. Anaesthesia, 2013, 68(6): 628-635.
42. Carli F, Clemente A. Regional anesthesia and enhanced recovery after surgery. Minerva Anestesiol, 2014, 80(11): 1228-1233.
43. 古麗娜·塔林巴依, 安玉潔, 劉玉革, 等. 兩種不同麻醉方式在肝包蟲病患者中的應用價值分析. 中西醫結合心血管病電子雜志, 2020, 8(26): 2-4.
44. 陳慶彬, 唐璟. 不同麻醉方式對肝包蟲手術中應激反應的影響. 青海醫藥雜志, 2023, 53(9): 11-14.
45. Ball J. How useful is the bispectral index in the management of ICU patients?. Minerva Anestesiol, 2002, 68(4): 248-251.
46. Savage RM, Aronson S原著. 李立環主譯. 術中經食管超聲心動圖. 北京: 人民衛生出版社, 2011: 214-247.
47. 經食管超聲心動圖臨床應用中國專家共識專家組. 經食管超聲心動圖臨床應用中國專家共識. 中國循環雜志, 2018, 33(1): 11-23.
48. 姜徽, 汪歡, 黃丹, 等. 肺保護性通氣策略對高原地區肝包蟲根治術患者術后氧合功能的影響. 麻醉安全與質控, 2020, 4(6): 341-344.
49. 易慧敏, 蔡常潔, 陸敏強, 等. 肝移植術后急性肺損傷的治療策略. 中華外科雜志, 2006, 44(13): 889-893.
50. Yamamoto K, Ishizawa T, Kokudo N. Laparoscopic hepatectomy under epidural anesthesia. Ann Surg, 2014, 260(2): e1. doi: 10.1097/SLA.0000000000000816.
51. 史佳, 余劍波, 宮麗榮, 等. 電針減輕內毒素休克誘發兔急性肺損傷的機制: 與Nrf2/ARE通路的關系. 中華麻醉學雜志, 2014, 34(7): 843-847.
52. 任秋生, 王均爐, 陳雪琴, 等. 經皮穴位電刺激合谷足三里對單肺通氣所致炎性反應的抑制作用. 中華中醫藥學刊, 2011, 29(10): 2326-2328.
53. McLain N, Parks S, Collins MJ. Perioperative goal-directed fluid therapy: a prime component of enhanced recovery after surgery. AANA J, 2021, 89(4): 351-357.
54. Virág M, Rottler M, Gede N, et al. Goal-directed fluid therapy enhances gastrointestinal recovery after laparoscopic surgery: a systematic review and meta-analysis. J Pers Med, 2022, 12(5): 734. doi: 10.3390/jpm12050734.
55. 梁超琴, 張光英, 林成新, 等. 以脈壓變異率為目標導向的液體治療在開腹肝臟手術中的應用效果. 廣西醫學, 2021, 43(2): 155-159.
56. Wrzosek A, Jakowicka-Wordliczek J, Zajaczkowska R, et al. Perioperative restrictive versus goal-directed fluid therapy for adults undergoing major non-cardiac surgery. Cochrane Database Syst Rev, 2019, 12(12): CD012767. doi: 10.1002/14651858.CD012767.pub2.
57. Chu MW, Losenno KL, Moore K, et al. Blood conservation strategies reduce the need for transfusions in ascending and aortic arch surgery. Perfusion, 2013, 28(4): 315-321.
58. 樊理華, 王建平, 鄭旺福, 等. 術前預防性應用烏司他丁對肝切除術中血液保護作用的影響. 臨床外科雜志, 2005, 13(5): 309-310.
59. 朱榮濤, 郭文治, 李捷, 等. 控制性低中心靜脈壓在腹腔鏡肝葉切除術中的應用. 中國普通外科雜志, 2018, 27(1): 42-48.
60. 王庚, 吳新民. 急性等容性血液稀釋與凝血狀態. 中華麻醉學雜志, 2001, 21(11): 645-648.
61. 盛博, 張幫健, 楊昶. 控制性低中心靜脈壓聯合急性高容性血液稀釋在右半肝切除術中的應用. 四川醫學, 2017, 38(12): 1403-1406.
62. 夏宗敬, 謝琳麗, 廖刃, 等. POTTS指導高原地區高血紅蛋白患者輸血安全有效性的研究. 西藏醫藥, 2019, 40(1): 7-8.
63. Knaepel A. Inadvertent perioperative hypothermia: a literature review. J Perioper Pract, 2012, 22(3): 86-90.
64. Zhou YD, Zhang WY, Xie GH, et al. Inadvertent perioperative hypothermia and surgical site infections after liver resection. Hepatobiliary Pancreat Dis Int, 2023, S1499-3872(23): 00244-8. doi: 10.1016/j.hbpd.2023.12.006.
65. Dieu A, Huynen P, Lavand’homme P, et al. Pain management after open liver resection: Procedure-Specific Postoperative Pain Management (PROSPECT) recommendations. Reg Anesth Pain Med, 2021, 46(5): 433-445.
66. Sessler DI, Pei L, Li K, et al. Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial. Lancet, 2022, 399(10337): 1799-1808.
67. 次仁德吉, 王盈兵. 成人肝包蟲手術的麻醉管理. 西藏醫藥, 2019, 40(3): 42-43.
68. 蔡誠毅, 馬武華. 全麻誘導后支氣管痙攣一例. 臨床麻醉學雜志, 2012, 28(5): 453.
69. 劉冬杰. 肝包蟲內囊摘除術中支氣管痙攣、過敏性休克1例的麻醉處理. 臨床合理用藥雜志, 2009, 2(8): 48.
70. Paksoy Y, Odev K, Sahin M, et al. Percutaneous treatment of liver hydatid cysts: comparison of direct injection of albendazole and hypertonic saline solution. AJR Am J Roentgenol, 2005, 185(3): 727-734.
71. Albi A, Baudin F, Matmar M, et al. Severe hypernatremia after hypertonic saline irrigation of hydatid cysts. Anesth Analg, 2002, 95(6): 1806-1808.
72. Yun G, Baek SH, Kim S. Evaluation and management of hypernatremia in adults: clinical perspectives. Korean J Intern Med, 2023, 38(3): 290-302.
73. Kuzmanovska B, Kartalov A, Kuzmanovski I, et al. Hypernatremia-induced neurologic complications after hepatic hydatid cyst surgery: pretreat to prevent. Med Arch, 2019, 73(5): 356-358.
74. 肖迪, 時瑩慶, 關巍, 等. 高原環境在血栓形成及血栓栓塞性疾病發病中作用的研究進展. 山東醫藥, 2017, 57(47): 102-106.
75. Melloul E, Dondéro F, Vilgrain V, et al. Pulmonary embolism after elective liver resection: a prospective analysis of risk factors. J Hepatol, 2012, 57(6): 1268-1275.
76. Ejaz A, Spolverato G, Kim Y, et al. Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg, 2014, 18(6): 1116-1124.
77. Turley RS, Reddy SK, Shortell CK, et al. Venous thromboembolism after hepatic resection: analysis of 5 706 patients. J Gastrointest Surg, 2012, 16(9): 1705-1714.
78. Bell BR, Bastien PE, Douketis JD, et al. Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review. Can J Anaesth, 2015, 62(2): 194-202.
79. Lui B, Wee B, Lai J, et al. A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant—Has venous thromboembolism treatment become safer?. Thromb Res, 2022, 219: 112-120.
80. Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv, 2020, 4(19): 4693-4738.
81. Stevens SM, Woller SC, Baumann Kreuziger L, et al. Executive summary: antithrombotic therapy for VTE disease: Second update of the CHEST guideline and expert panel report. Chest, 2021, 160(6): 2247-2259.
82. Crile GW. The kinetic theory of shock and its prevention through anoci-association. Lancet, 1913, 185: 7-16.
83. Xuan C, Yan W, Wang D, et al. Efficacy of preemptive analgesia treatments for the management of postoperative pain: a network meta-analysis. Br J Anaesth, 2022, 129(6): 946-958.
84. 翁方澤, 吳維, 朱嶺, 等. 納布啡超前鎮痛模式在腹腔鏡肝部分切除手術中的臨床應用效果探究. 江漢大學學報(自然科學版), 2022, 50(5): 69-74.
85. 楊秋紅, 戴曉薇, 張益維, 等. 帕瑞昔布超前鎮痛對開腹肝切除術后疼痛及應激、炎癥反應的影響. 中國衛生檢驗雜志, 2019, 29(21): 2632-2634.
86. Doleman B, Leonardi-Bee J, Heinink TP, et al. Pre-emptive and preventive NSAIDs for postoperative pain in adults undergoing all types of surgery. Cochrane Database Syst Rev, 2021, 6(6): CD012978. doi: 10.1002/14651858.CD012978.pub2.
87. Bai JW, An D, Perlas A, et al. Adjuncts to local anesthetic wound infiltration for postoperative analgesia: a systematic review. Reg Anesth Pain Med, 2020, 45(8): 645-655.
88. Ballantyne JC, Carr DB, deFerranti S, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg, 1998, 86(3): 598-612.
89. 高琳, 劉玉革. 肝包蟲囊外切除病人術后不同鎮痛方法的比較. 西部醫學, 2009, 21(1): 73-75.
90. 文成措. 不同麻醉鎮痛方式對肝包蟲手術患者術后轉歸的影響. 臨床醫藥文獻電子雜志, 2020, 7(7): 19.
91. Su W, Deng X, Li X, et al. Effect of the transversus abdominis plane block on postoperative pain and recovery in patients with hepatic echinococcosis. J Int Med Res, 2018, 46(9): 3563-3569.
92. Daghmouri MA, Mesbahi M, Akremi S, et al. Efficacy of bilateral erector spinae block for post-operative analgesia in liver hydatid surgery. Br J Pain, 2021, 15(4): 376-379.
93. Verhoef C, Singla N, Moneta G, etal. Fibrocaps for surgical hemostasis: two randomized, controlled phase Ⅱ trials. J Surg Res, 2015, 194(2): 679-687.
94. Joliat GR, Kobayashi K, Hasegawa K, et al. Guidelines for perioperative care for liver surgery: Enhanced Recovery After Surgery (ERAS) society recommendations 2022. World J Surg, 2023, 47(1): 11-34.
95. Darvall JN, Handscombe M, Leslie K. Chewing gum for the treatment of postoperative nausea and vomiting: a pilot randomized controlled trial. Br J Anaesth, 2017, 118(1): 83-89.
96. Chen X, Chang C, Yuan X, et al. Efficacy and safety of preoperative chewing gum for undergoing elective surgery: A meta-analysis of randomised controlled trials. J Clin Nurs, 2023, 32(15-16): 4295-4310.
97. 陳鳳, 楊雪, 劉麗, 等. 內關穴按壓改善癌癥病人化療相關性惡心、嘔吐效果的Meta分析. 護理研究, 2020, 34(9): 1535-1541.
98. 周璇, 王琦. 穴位按壓腕帶緩解術后惡心嘔吐隨機對照試驗的Meta分析. 護理學雜志, 2011, 26(6): 81-84.
99. Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: Advances in the 21st century. Clin Microbiol Rev, 2019, 32(2): e00075-18. doi: 10.1128/CMR.00075-18.

Previous Article
Advances in research and development of echinococcosis vaccines
Next Article
Progress in medical treatment of echinococcosis

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Anesthesia management in hepatic echinococcosis surgery

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content